{
    "eid": "2-s2.0-85168445119",
    "title": "Correlations between histopathologic findings, serum biomarker levels, and clinical outcomes in Stevens\u2013Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)",
    "cover-date": "2023-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Donlaporn Chuenwipasakul",
        "Chanudda Washrawirul",
        "Rawiphan Panpruk",
        "Jade Wititsuwannakul",
        "Kridipop Charoenchaipiyakul",
        "Supranee Buranapraditkun",
        "Vilavun Puangsricharern",
        "Jettanong Klaewsongkram",
        "Pawinee Rerknimitr"
    ],
    "citedby-count": 0,
    "ref-count": 55,
    "ref-list": [
        "Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis",
        "Current pharmacogenetic perspective on Stevens\u2013Johnson syndrome and toxic epidermal necrolysis",
        "SJS/TEN 2019: From science to translation",
        "Treating toxic epidermal necrolysis with systemic immunomodulating therapies: A systematic review and network meta-analysis",
        "Long-term physical and psychological outcomes of Stevens\u2013Johnson syndrome/toxic epidermal necrolysis",
        "Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies",
        "Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: A review of diagnosis and management",
        "Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome",
        "Assessment of treatment approaches and outcomes in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: Insights from a pan-European multicenter study",
        "Improvement of mortality prognostication in patients with epidermal necrolysis: The role of novel inflammatory markers and proposed revision of SCORTEN (Re-SCORTEN)",
        "Clinical parameters and biological markers associated with acute severe ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Predictive factors associated with acute ocular involvement in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis",
        "Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: An update",
        "Assessment and comparison of performance of ABCD-10 and SCORTEN in prognostication of epidermal necrolysis",
        "Prognostic value of histologic features of toxic epidermal necrolysis",
        "Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis",
        "Granulysin is a key mediator for disseminated keratinocyte death in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis",
        "Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis",
        "Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis",
        "Increased soluble Fas ligand levels in patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis preceding skin detachment",
        "Histopathological and immunohistochemical features of drug-induced exanthems",
        "Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity",
        "Serum miR-124 up-regulation as a disease marker of toxic epidermal necrolysis",
        "RIP3 as a diagnostic and severity marker for Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "High S100A2 expression in keratinocytes in patients with drug eruption",
        "Diverse expression of TNF-\u03b1 and CCL27 in serum and blister of Stevens\u2013Johnson syndrome/toxic epidermal necrolysis",
        "Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions",
        "Interleukin-15 is associated with severity and mortality in stevens-johnson syndrome/toxic epidermal necrolysis",
        "Galectin-7 as a potential biomarker of Stevens-Johnson syndrome/toxic epidermal necrolysis: Identification by targeted proteomics using causative drug-exposed peripheral blood cells",
        "RIP3 as a diagnostic and severity marker for Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis",
        "Diagnosis and management of Stevens\u2013Johnson syndrome/toxic epidermal necrolysis",
        "Immunologic mediators in stevens-johnson syndrome and toxic epidermal necrolysis",
        "Variable levels of apoptotic signal-associated cytokines in the disease course of patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis",
        "Cytokines/Chemokines: Novel biomarkers associated with severe cutaneous adverse reactions",
        "The Roles of immunoregulatory networks in severe drug hypersensitivity",
        "Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN)",
        "Underexpression and overexpression of fas and fas ligand: a double-edged sword",
        "Diagnostic tools and biomarkers for severe drug eruptions",
        "Diagnostic role of soluble fas ligand secretion by peripheral blood mononuclear cells from patients with previous drug-induced blistering disease: A pilot study",
        "Erythropoietin, stem cell factor, and cancer cell migration",
        "Role of stem cell factor in the placental niche",
        "Myeloperoxidase as an active disease biomarker: Recent biochemical and pathological perspectives",
        "Prognostic role of elevated myeloperoxidase in patients with acute coronary syndrome: A systemic review and meta-analysis",
        "The many roles of myeloperoxidase: From inflammation and immunity to biomarkers, drug metabolism and drug discovery",
        "Functionally active macrophage-derived myeloperoxidase in the skin of drug-induced toxic epidermal necrolysis",
        "Neutrophils initiate and exacerbate Stevens\u2013Johnson syndrome and toxic epidermal necrolysis",
        "Neutrophil: Lymphocyte ratio is associated with disease severity and mortality in patients with Stevens\u2013Johnson syndrome/toxic epidermal necrolysis",
        "Key factors predicting the in-hospital mortality of patients with severe cutaneous adverse reactions in Thailand",
        "S100A8/A9 in Inflammation",
        "S100A8/A9: From basic science to clinical application",
        "Keratinocyte injury in drug-induced toxic epidermal necrolysis: Simultaneous but distinct topographic expression of CD95R and calprotectin",
        "Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea & Westminster TEN protocol",
        "Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme",
        "ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: Comparison with case-control analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "60029201",
            "affilname": "Chonburi Regional Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029201",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Skin and Allergy Research Unit",
        "Chulalongkorn University"
    ]
}